The Top
We Build Precision Biomarkers
Biomarkers in Development
Kernel's AI and ML tools produce actionable biomarkers that take advantage of the volume of information-rich data that can quickly be gathered with Flow.
Depression
Active
Enrolling by invitation in clinics across the West Coast for a biomarker study measuring various depression treatments.
Learn More At
Cognitive
Decline
Recruitment Complete
Recruiting healthy controls and MCI patients for a biomarker study measuring aging in adults over the age of 55.
Learn More At
Validation Biomarkers
Kernel has demonstrated the ability to measure known functional changes in the brain in response to administering psychoactive substances. These results validate the biomarker capabilities of our system and demonstrate a key capability used in Phase I studies with our biopharma partners.
Further Reading
Our Publications
Reliability of brain metrics derived from a Time-Domain Functional Near-Infrared Spectroscopy System
Scientific Reports · July 30, 2024
Read MoreMeasuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS
Scientific Reports · July 19, 2023
Read MoreChange in brain asymmetry reflects level of acute alcohol intoxication and impacts on inhibitory control
Scientific Reports · June 24, 2023
Read MoreKernel Flow: a high channel count scalable time-domain functional near-infrared spectroscopy system
Journal of Biomedical Optics · January 18, 2022
Read MoreOther Flow Publications
Assessing changes in regional cerebral hemodynamics in adults with a high-density full-head coverage time-resolved near-infrared spectroscopy device
Journal of Biomedical Optics · May 3, 2024
Read MoreWearable, high-density fNIRS and diffuse optical tomography technologies: a perspective
Neurophotonics · May 17, 2023
Read MoreCurrent opinions on the present and future use of functional near-infrared spectroscopy in psychiatry
Neurophotonics · February 7, 2023
Read MoreHow much do time-domain functional near-infrared spectroscopy (fNIRS) moments improve estimation of brain activity over traditional fNIRS?
Neurophotonics · October 22, 2022
Read MoreOptical imaging and spectroscopy for the study of the human brain: status report
Neurophotonics · August 30, 2022
Read More
Partner With Us
Together, we can revolutionize precision neuromedicine.
As the leader in non-invasive brain measurement, Kernel believes in data-driven development and scalable technology. Our brain-based biomarkers, action-focused solutions, and reliable data can empower and accelerate your goals. Transform the future of neuromedicine today by partnering with us.
